Ambiguous Capture: Collaborative Capitalism and the Meningitis Vaccine Project

References

• Abraham, J. 1995 Science, politics and the pharmaceutical industry: Controversy and bias in drug regulation. London: UCL Press.
   Google Scholar
• Aguado, M. T., L. Jodar, D. Granoff, R. Rabinovich, C. Ceccarini, and G. W. Perkin 2015 From epidemic meningitis vaccines for Africa to the Meningitis Vaccine Project. Clinical Infectious Diseases 61(S5): S391–S395.
   PubMed Web of Science ®Google Scholar
• Atun, R. A., S. Bennett, and A. Duran 2008 When do vertical (stand-alone) programmes have a place in health system? Copenhagen, Denmark: WHO Regional Office for Europe and European Observatory and Health Systems and Policies.
   Google Scholar
• Barr, D. 2007 A research protocol to evaluate the effectiveness of public–private partnerships as a means to improve health and welfare systems worldwide. American Journal of Public Health 97(1):19–25.
   PubMed Web of Science ®Google Scholar
• Berlier, M., R. Barry, J. Shadid, C. Sirica, A. Brunier, H. Hasan, and E. Bouma 2015 Communication challenges during the development and introduction of a new meningococcal vaccine in Africa. Clinical Infectious Diseases 61(S5): S451–S458.
   PubMed Web of Science ®Google Scholar
• Bishai, D. M., C. Champio, M. E. Steele, and L. Thompson 2011 Product development partnerships hit their stride: Lessons from developing a Meningitis vaccine for Africa. Health Affairs 30(6):1058–1064.
   Web of Science ®Google Scholar
• Blume, S. 2008 Towards a history of the vaccine innovation system, 1950–2000. In Biomedicine in the Twentieth Century: Practices, Policies, and Politics. C. Hannaway, ed. Pp. 255–286. Washington, DC: IOS Press.
   Google Scholar
• Blume, S. and I. Geesink 2000 Vaccinology: An industrial science? Science as Culture 9(1):41–72.
   Google Scholar
• Blume, S., J. Jani, and S. Roalkvam 2013 Saving children’s lives: Perspectives on immunization. In Protecting the World’s Children: Immunization Policies and Practices. S. Roalkvam, D. McNeill, and S. Blume, eds. Pp. 1–30. Oxford, UK: Oxford University Press.
   Google Scholar
• British Medical Journal 2016 BMJ Open Data Campaign. http://www.bmj.com/open-data.
   Google Scholar
• Brown, T. M., M. Cueto, and E. Fee 2006 The World Health Organization and the transition from international to global public health. American Journal of Public Health 96(1):62–72.
   PubMed Web of Science ®Google Scholar
• Burchett, H. E. D., S. Mounier-Jack, S. U. K. Griffiths, R. Biellik, P. Ongolo-Zogo, E. Chavez, H. Sarma, et al. 2012 New vaccine adoption: Qualitative study of national decision-making processes in seven low- and middle-income countries. Health Policy and Planning 27: ii5–ii16.
   Google Scholar
• Burchett, H. E. D., S. Mounier-Jack, S. Torres-Rueda, U. K. Griffiths, P. Ongolo-Zogo, S. Rulisa, J.-M. Edengue, et al. 2014 The impact of introducing new vaccines on the health system: Case studies from six low- and middle-income countries. Vaccine 32(48):6505–6512.
   PubMed Web of Science ®Google Scholar
• Carpenter, D. 2013 Corrosive capture? The dueling forces of autonomy and industry influence in FDA pharmaceutical regulation. In Preventing Regulatory Capture: Special Interest Influence and How to Limit it. D. Carpenter and D. Moss, eds. Pp. 152–172. Cambridge, UK: Cambridge University Press.
   Google Scholar
• Caryn-Rabin, R. 2012 Reassessing flu shots as the season draws near. New York Times, November 5: http://well.blogs.nytimes.com/2012/11/05/reassessing-flu-shots-as-the-season-draws-near/?_r=0.
   Google Scholar
• Caugant, D. A., P. A. Kristiansen, X. Wang, L. W. Mayer, T. Muhamed-Kheir, R. Oue´draogo, D. Kandolo, F. Bougoudogo, S. Sow, and L. Bonte 2012 Molecular characterization of invasive meningococcal isolates from countries in the African Meningitis Belt before introduction of a serogroup A conjugate vaccine. PLoS ONE 7 (9):e46019.
   PubMed Web of Science ®Google Scholar
• Cavalli, A., S. I. Bamba, M. N. Traore, M. Boelaret, Y. Coulibaly, K. Polman, and M. Pirar 2010 Interactions between global health initiatives and country health systems: The case of a neglected tropical diseases control program in Mali. PLoS Neglected Tropical Diseases 4 (8):e798.
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention 2011 Epidemiology of Meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenza. In Laboratory Methods for the Diagnosis of Meningitis. 2nd edition. http://www.cdc.gov/meningitis/lab-manual/chpt02-epi.html.
   Google Scholar
• Clemens, J. and L. Jódar 2005 Introducing new vaccines into developing countries: Obstacles, opportunities and complexities. Nature Medicine Supplement 11(4):S12–S15.
   PubMed Web of Science ®Google Scholar
• Closser, S. 2010 Chasing Polio in Pakistan. Nashville, TN: Vanderbilt University Press.
   Google Scholar
• Cohen Marill, M. 2015 After flu vaccine mismatch, calls for delayed selection intensify. Nature Medicine 21:297–298.
   Google Scholar
• Colombini, A., O. Badolo, B. D. Gessner, P. Jaillard, E. Seini, and A. Da Silva 2011 Costs and impact of meningitis epidemics for the public health system in Burkina Faso. Vaccine 29:5474–5480.
   PubMed Web of Science ®Google Scholar
• Daugla, D. M., J. P. Gami, K. Gamougam, N. Naibei, L. Mbainadji, M. Narbé, J. Toralta, et al. 2014 Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community trial. The Lancet 383:40–47.
   PubMed Web of Science ®Google Scholar
• Deer, B. 2011 How the case against the MMR vaccine was fixed. British Medical Journal 342: c5347.
   PubMed Web of Science ®Google Scholar
• Delrieux, I., S. Yaro, T. A. Tamekloé, B. M. Njanpop-Lafourcade, H. Tall, P. Jaillard, M. S. Ouedraogo, et al. 2011 Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS ONE 6:e19513.
   Google Scholar
• Djibo, S., P. Nicolas, J. M. Alonso, A. Djibo, D. Couret, J. Y. Riou, and J. P. Chippaux 2003 Outbreaks of serogroup X meningococcal meningitis in Niger 1995–2000. Tropical Medicine and International Health 8(12):1118–1123.
   PubMed Web of Science ®Google Scholar
• Dunn, A. G., D. Arachi, J. Hudgins, G. Tsafnat, E. Colera, and F. T. Bourgeois 2014 Financial conflicts of interest and conclusions about neuraminidase inhibitors for influenza. Annals of Internal Medicine 161:513–518.
   Google Scholar
• Forman, D., C. de Martel, C. J. Lacey, I. Soerjomantaram, J. Lortet-Tieulent, L. Bruni, J. Vignat, et al. 2012 Global burden of human papillomavirus and related diseases. Vaccine 30 (Suppl5): F12–23.
   PubMed Web of Science ®Google Scholar
• Funk, A., K. Uadiale, C. Kamau, D. A. Caugant, U. Ango, and J. Greig 2014 Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013–2014. PLoS Currents. 6: ecurrents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518.
   Google Scholar
• Gagneaux, S., T. Wirth, A. Hodgson, I. Ehrhard, G. Morelli, P. Kriz, B. Genton, T. et al. 2002 Clonal groupings in serogroup X Neisseria meningitidis. Emerging Infectious Diseases 8(5):462–466.
   PubMed Web of Science ®Google Scholar
• Gagnon, M. A. 2011 Rethinking the social determinants of value in cognitive capitalism. European Journal of Economic and Social Systems 1–2:119–136.
   Google Scholar
• GAVI ALLIANCE 2014a Meningitis A vaccine support. GAVI Alliance: Types of support. http://www.gavi.org/support/nvs/meningitis-a/.
   Google Scholar
• Godlee, F., J. Smith, and H. Marcovitch 2011Wakefield’s article linking MMR vaccine and autism was fraudulent. British Medical Journal 342:c7452.
   PubMed Web of Science ®Google Scholar
• Graham, J. E. 2008 Facilitating regulation: The dance of statistical significance and clinical meaningfulness in standardizing technologies for dementia. BioSocieties 3(3):241–263.
   Web of Science ®Google Scholar
• Graham, J. E. and A. Mishra 2011 Global challenges of implementing human papillomavirus vaccines. International Journal for Equity in Health 10 (1):27.
   PubMed Web of Science ®Google Scholar
• Graham, J. E., A. Borda-Rodrigeuz, F. Huzair, and E. Zinck 2012 Capacity for a global vaccine safety system: The perspective of national regulatory authorities. Vaccine 30(33):4953–4959.
   PubMed Web of Science ®Google Scholar
• Hamidi, A., C. Boog, S. Jadhav, and H. Kreeftenberg 2014 Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to emerging vaccine manufacturers. Vaccine 32(33):4124–4130.
   PubMed Web of Science ®Google Scholar
• Hardon, A. 1990 Ten best readings in … the Bamako Initiative. Health Policy and Planning 5 (2):186–189.
   Google Scholar
• Huzair, F., A. Borda-Rodriguez, and M. Upton 2011Twenty-first century vaccinomics innovation systems: Capacity building in the global south and the role of product development partnerships (PDPS). Omics A Journal of Integrative Biology 15(9):539–543.
   Web of Science ®Google Scholar
• Hyde, T. B., H. Dentz, S. A. Wang, H. E. Burchett, S. Mounier-Jack, and C. F. Mantel 2012 The impact of new vaccine introduction on immunization and health systems: A review of the published literature. Vaccine 30(45):6347–6358.
   PubMed Web of Science ®Google Scholar
• Idoko, O. T., A. Diallo, S. O. Sow, A. Hodgson, A. Akinsola, B. Diarra, F. C. Haidara, Pet al. 2015 Community perspectives associated with the African PsA-TT(MenAfriVAc) vaccine trials. Clinical Infectious Diseases 61(S5): S416–S421.
   PubMed Web of Science ®Google Scholar
• Jódar L., F. M. LaForce, C. Ceccarini, T. Aguado, and D. M. Granoff 2003 Meningococcal conjugate vaccine for Africa: A model for development of new vaccines for the poorest countries. The Lancet 361(9372):1902–1904.
   PubMed Web of Science ®Google Scholar
• Kaler A. 2009 Health interventions and the persistence of rumour: The circulation of sterility stories in African public health campaigns. Social Science & Medicine 68: 1711–1719.
   PubMed Web of Science ®Google Scholar
• Kickbusch, I. and L. Payne 2004 Constructing Global Public Health in the 21st Century. Paper presented at the Meeting of the Global Health Governance and Accountability, Cambridge, MA, June 2–3.
   Google Scholar
• Lakoff, A. 2005 Pharmaceutical Reason: Knowledge and Value in Global Psychiatry. Cambridge, UK: Cambridge University Press.
   Google Scholar
• LaForce, F. M. and J. M. Okwo-Bele 2011 Eliminating epidemic group A Meningococcal Meningitis in Africa through a new vaccine. Health Affairs 30(6):1049–1057.
   PubMed Web of Science ®Google Scholar
• Lapeyssonie, L. 1963 La méningite cérébrospinale en Afrique. Bulletin of the World Health Organization 28 ( Suppl):3–114.
   Google Scholar
• Larson, H. and W. Schulz 2015 The State of Vaccine Confidence. The Vaccine Confidence Project, London School of Hygiene & Tropical Medicine. www.vaccineconfidence.org.
   Google Scholar
• Latour, B. 1987 Science in Action: How to Follow Scientists and Engineers through Society. Cambridge, MA: Harvard University Press.
   Google Scholar
• Leach. M. and J. Fairhead 2007 Vaccine Anxieties: Global Science, Child Health and Society. London: Earthscan Publications.
   Google Scholar
• Light, D. W. 2009 Advanced market commitments. Current realities and alternate approaches. Health Action International (HAI) Europe, Paper series reference 03-2009/01. http://www.haiweb.org/31032009/27%20Mar%202009%20AMC%20Current%20Realities%20&%20Alternate%20Approaches%20FINAL.pdf.
   Google Scholar
• Light, D. W., J. Lexchin, and J. J. Darrow 2013 Institutional corruption of pharmaceuticals and the myth of safe and effective drugs. Journal of Law, Medicine and Ethics 14(3):590–610.
   Web of Science ®Google Scholar
• Lippman, A., R. Melnychuk, C. Shimmin, and M. Boscoe 2007 Human papillomavirus, vaccines and women’s health: questions and cautions. Canadian Medical Association Journal 177(5):484–487.
   Web of Science ®Google Scholar
• Löwy, I. and P. Zylberman 2000 Medicine as a social instrument: Rockefeller Foundation, 1913–45. Studies in History and Philosophy of Science 31(3):365–379.
   Google Scholar
• Marchal, B., A. Cavalli, and G. Kegels 2009 Global health actors claim to support health system strengthening—Is this reality or rhetoric? PLoS Med 6 (4):e1000059. doi:10.1371/journal.pmed.1000059
   PubMed Web of Science ®Google Scholar
• Marchetti, E., V. Mazarin-Diop, J. Chaumont, L. Martellet, M. F. Makadi, S. Viviani, P. S. Kulkarni, and M. P. Preziosi 2012 Conducting vaccine clinical trials in sub-Saharan Africa: operational challenges and lessons learned from the Meningitis Vaccine Project. Vaccine 30(48):6859–6863.
   PubMed Web of Science ®Google Scholar
• Mazzucato, M. 2013 The Entrepreneurial State: Debunking Public vs. Private Sector Myth. London: Anthem Press.
   Google Scholar
• McGoey, L. 2012 Strategic unknowns: Towards a sociology of ignorance. Economy and Society 41(1):1–16.
   Web of Science ®Google Scholar
• McGoey, L.. 2014 The philanthropic state: Market-state hybrids in the philanthrocapitalist turn. Third World Quarterly 35(1):109–125.
   Web of Science ®Google Scholar
• Meningitis Vaccine Project 2013 News Digest 37( Q3). http://www.meningvax.org/files/MVP_newsdigest_2013_Q3_37.pdf.
   Google Scholar
• Mills, A. 2005 Mass campaigns versus general health services: What have we learnt in 40 years about vertical versus horizontal approaches? Bulletin of the World Health Organization 83(4):315–316.
   PubMed Web of Science ®Google Scholar
• Mishra, A. and J. E. Graham 2012 Risk, choice and the ‘girl’ vaccine: Unpacking HPV immunization. Health, Risk & Society 14(1):57–69.
   Web of Science ®Google Scholar
• Mounier-Jack, S., U. K. Griffiths, S. Closser, H. Burchett, and B. Marchal 2014 Measuring the health systems impact of disease control systems: A critical reflection on the WHO building blocks framework. BMC Public Health 14278. http://www.biomedcentral.com/1471-2458/14/2778.
   Web of Science ®Google Scholar
• Mounier-Jack, S., H. E. D. Burchett, U. K. Griffiths, M. Konate, and K. S. Diarra 2014 Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system. Global Health: Science and Practice 2(1):117–129.
   PubMedGoogle Scholar
• Muraskin, W 2005 Crusade to Immunize the World’s Children. USA: Global Bio Business Books.
   Google Scholar
• Nik-Khah, E. 2014 Neoliberal pharmaceutical science and the Chicago School of Economics. Social Studies of Science 44(4):489–517.
   PubMed Web of Science ®Google Scholar
• Novak, R. T., J. L. Kambou, F. V. K. Diomandé, T. F. Tarbangdo, R. Ouédraogo-Traoré, L. S. C. Lingani, S. W. Martin, et al. 2012 Serogroup A meningococcal conjugate vaccination in Burkina Faso: Analysis of national surveillance data. Lancet Infectious Diseases 12:757–764.
   PubMed Web of Science ®Google Scholar
• Open Trials 2016 Open trials. All the data, on all the trials. http://opentrials.net/.
   Google Scholar
• Osterholm, M. T., N. S. Kelley, J. M. Manske, K. S. Ballering, T. R. Leighton, and K. A. Moore 2012 The compelling need for game-changing influenza vaccines: An analysis of the influenza vaccine enterprise and recommendations for the future. Center for Infectious Diseases Research & Policy (CIDRAP) Report. Minneapolis, MN: University of Minnesota. http://www.cidrap.umn.edu/sites/default/files/public/downloads/ccivi_report.pdf.
   Google Scholar
• Petryna, A. 2009 When Experiments Travel: Clinical Trials and the Global Search for Human Subjects. Princeton, NJ: Princeton University Press.
   Google Scholar
• Petryna A., A. Kleinman, and A. Lakoff 2006 Global Pharmaceuticals: Ethics, Markets, Practices. Durham, NC: Duke University Press.
   Google Scholar
• Pham-Kanter, G. 2014 Revisiting financial conflicts of interest in FDA advisory committees. The Millbank Quarterly 92(3):446–470.
   PubMed Web of Science ®Google Scholar
• Rappuoli, R. 2003 The real cost of an affordable vaccine for Meningococcus A. Lancet 362:250–251.
   Google Scholar
• Reid-Henry, S. M. 2010 The Cuban Cure: Reason and Resistance in Global Science. Chicago: University of Chicago Press
   Google Scholar
• Renne E. 2006 Perspectives on polio and immunization in Northern Nigeria. Social Science & Medicine 64:1857–1869.
   Web of Science ®Google Scholar
• Rottenburg, R. 2009 Far-fetched facts: A parable of development aid. Cambridge, MA: MIT Press.
   Google Scholar
• Sié, A. 2013 Bacterial meningitis in Nouna Health District, Burkina Faso: From the understanding of the dynamics of colonization and disease to improved health control. PhD dissertation, Faculty of Medicine, University of Heidelberg.
   Google Scholar
• Sow, S., B. J. Okoko, A. Diallo, S. Viviani, R. Borrow, G. Carlone, M. Tapia, et al. 2011 Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. New England Journal of Medicine 364:2293–2304.
   PubMed Web of Science ®Google Scholar
• Storeng, K. T. 2014 The GAVI Alliance and the ‘Gates approach’ to health system strengthening. Global Public Health 9(8):865–879.
   PubMed Web of Science ®Google Scholar
• Thorsteinsdóttir, H., T. W. Sáenz. U. Quash, A. S. Daar, and P. A. Singer 2004 Cuba—Innovation through synergy. Nature Biotechnology 22 (Suppl):DC19–24.
   PubMed Web of Science ®Google Scholar
• Tiffay, K., L. Jodar, M.-P. Kieny, M. Socquet, and F. M. LaForce 2015 The evolution of the Meningitis Vaccine Project. Clinical Infectious Diseases 61(S6): S396–403.
   PubMed Web of Science ®Google Scholar
• Tomljenovi, L. and C. A. Shaw 2012 Too fast or not too fast: the FDA’s approval of Merck’s HPV vaccine Gardasil. Conflicts of interest in the practice of medicine. Journal of Law, Medicine & Ethics 40(3):673–681.
   PubMed Web of Science ®Google Scholar
• Traoré, Y., T. A. Tameklo, B. M. Njanpop-Lafourcade, M. Lourd, S. Yaro, D. Niamba, A. Drabo, J. E. Mueller, J. L. Koeck, and B. D. Gessner 2009 Incidence, seasonality, age distribution, and mortality of Pneumococcal meningitis in Burkina Faso and Togo. Clinical Infectious Diseases 48 (Suppl2):181–189.
   Web of Science ®Google Scholar
• UNICEF: United Nations Children’s Fund 1996 Sustainability of Achievements: Lessons Learned from Universal Child Immunization. Evaluation & Research. Report of a Steering Committee for Lessons Learned on Sustainability for Child Immunization. http://immunizationbasics.jsi.com/Docs/BASICS/UCISustainabilityReport.pdf.
   Google Scholar
• van Olmen J., B. Marchal, W. van Damme, G. Kegels, and P. S. Hill 2012 Health systems frameworks in their political context: Framing divergent agendas. BMC Public Health 12:774. doi:10.1186/1471-2458-12-774.
   PubMed Web of Science ®Google Scholar
• World Bank 2013 World Bank. http://data.worldbank.org/country/burkina-faso.
   Google Scholar
• World Health Organization 1997 Epidemic meningitis in Africa, 1997. Weekly Epidemiology Record 72:313–315.
   Google Scholar
• World Health Organization. 1999 Group A and C meningococcal vaccines. WHO position paper. Weekly Epidemiology Record 74:297–304.
   Google Scholar
• World Health Organization. 2007 Everybody’s Business: Strengthening Health Systems to Improve Health Outcomes. WHO’s Framework for Action. Geneva, Switzerland: World Health Organization. http://www.who.int/healthsystems/strategy/everybodys_business.pdf.
   Google Scholar
• World Health Organization. 2008 Media release. African countries to introduce new meningitis vaccine. The Yaoundé Declaration on the Elimination of Meningococcal A Meningitis Epidemics as a Public Health problem in Africa. http://www.who.int/mediacentre/news/releases/2008/pr31/en/.
   Google Scholar
• World Health Organization. 2009 Standard operating procedures for enhanced meningitis surveillance in Africa. Ouagadougou, Burkina Faso. Ouagadougou, Burkina Faso: WHO Regional Office for Africa.
   Google Scholar
• World Health Organization. 2013 Global Alert and Response (GAR). Meningococcal disease: 2013 epidemic season in the African Meningitis Belt. WHO Report June. http://www.who.int/csr/don/2013_06_06_menin/en/index.html.
   Google Scholar
• World Health Organization. 2015a WHO grants approval for safe, meningitis A vaccine for infants. http://www.who.int/immunization/newsroom/press/9_01_2015_meningitis_vaccine_who_approval/en/.
   Google Scholar
• World Health Organization. 2015b Intercountry Support Team—West Africa. Meningitis Weekly Bulletin Week 17. http://www.who.int/csr/disease/meningococcal/epidemiological/en/.
   Google Scholar